<!DOCTYPE html>
<!--[if lt IE 9]><html class="no-js lt-ie9" lang="en" dir="ltr"><![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js" lang="en" dir="ltr">
<!--<![endif]-->
<head>
<meta charset="utf-8" />
<!-- Web Experience Toolkit (WET) / Boîte à outils de l'expérience Web (BOEW)
wet-boew.github.io/wet-boew/License-en.html / wet-boew.github.io/wet-boew/Licence-fr.html -->

<title>ARCHIVED - Federal Framework on Lyme Disease Act</title>
<meta content="width=device-width, initial-scale=1" name="viewport" />
<!-- Meta data -->
<meta name="description" content="Federal laws of canada" />
<meta name="dcterms.title" content="Consolidated federal laws of canada, Federal Framework on Lyme Disease Act" />
<meta name="dcterms.creator" title="Department of Justice" content="Legislative Services Branch" />
<meta name="dcterms.issued" title="W3CDTF" content="2014-12-16" />
<meta name="dcterms.modified" title="W3CDTF" content="2014-12-16" />
<meta name="dcterms.subject" title="scheme" content="Consolidated federal laws of canada" />
<meta name="dcterms.language" title="ISO639-2" content="eng" />
<meta property="dcterms:accessRights" content="2" />
<meta property="dcterms:service" content="JUS-Laws_Lois" />
<!-- Meta data-->
<!--[if gte IE 9 | !IE ]><!-->
<link href="/theme-gcwu-fegc/assets/favicon.ico" rel="icon" type="image/x-icon" />
<link rel="stylesheet" href="/theme-gcwu-fegc/css/theme.css" />
<!--<![endif]-->

<!--[if lt IE 9]>
<link href="/theme-gcwu-fegc/assets/favicon.ico" rel="shortcut icon" />
<link rel="stylesheet" href="/theme-gcwu-fegc/css/ie8-theme.css" />
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.js"></script>
<script src="/wet-boew/js/ie8-wet-boew.js"></script>
<![endif]-->
<link rel="stylesheet" type="text/css" href="/css/browse.css">
<link rel="stylesheet" type="text/css" href="/css/lawContent.css?v=2">
<link rel="stylesheet" type="text/css" href="/css/commonView.css?v=2">
    <script src="//assets.adobedtm.com/be5dfd287373/bb72b7edd313/launch-e34f760eaec8.min.js"></script>

<noscript><link rel="stylesheet" href="/wet-boew/css/noscript.css" /></noscript>
</head>
<body vocab="http://schema.org/" typeof="WebPage">	
<ul id="wb-tphp">
<li class="wb-slc">
<a class="wb-sl" href="#wb-cont">Skip to main content</a>
</li>
<li class="wb-slc visible-sm visible-md visible-lg">
<a class="wb-sl" href="#wb-info">Skip to "About this site"</a>
</li>
<li class="wb-slc visible-md visible-lg">
<a class="wb-sl" href="#wb-sec">Skip to section menu</a>
</li>
</ul>


<header>
<!--#include virtual="/includes/banner-e.inc" -->
<!-- START BREADCRUMB -->
<nav id="wb-bc" property="breadcrumb">
<h2>You are here:</h2>
<div class="container">
<div class="row">
<ol class="breadcrumb"><li><a href="http://www.justice.gc.ca/eng">Home</a></li><li><a href="/eng">Laws Website Home</a></li><li><a href="/eng/acts/">Consolidated Acts</a></li><li><a href="../index.html"><abbr title='Statutes of Canada'>S.C.</abbr> 2014, c. 37 - &#x00A0;Table of Contents</a></li> <li><a href="../PITIndex.html"> Previous versions</a></li><li><abbr title='Statutes of Canada'>S.C.</abbr> 2014, c. 37</li></ol>
</div>
</div>
</nav>
</header>

<!-- START MAIN CONTENT AREA -->
<div class="container">
<div class="row">

<main property="mainContentOfPage" class="col-md-9 col-md-push-3">
<!--#include virtual="/includes/notice-e.inc" -->
<div class="archiveBar"><a href="/eng/ArchiveNote">This Web page has been archived on the Web.</a></div>
<div class="tocButtonBar"><a id="right-panel-trigger" class="overlay-lnk btn btn-default" role="button" href="#right-panel" aria-controls="right-panel">Table of Contents</a></div>
<div  id="wb-cont" class="docContents">
<section><div class="wb-txthl">
<div class="info">Version of document from 2014-12-16 to <!--#include file="iEndDate.inc" -->:</div>
<section class="intro"><header><h2 class='Title-of-Act'>Federal Framework on Lyme Disease Act</h2><p class='ChapterNumber'><abbr title='Statutes of Canada'>S.C.</abbr> 2014, c. 37</p></header><p class='AssentedDate'>Assented to 2014-12-16</p><p class='LongTitle' id='id-lt'>An Act respecting a Federal Framework on Lyme Disease</p></section>
<section class="order"><h6 id="preamble" class="MarginalNote">Preamble</h6><p class="indent-0-0" id="238706">Whereas Lyme disease is an illness caused by the bacterium <span class="otherLang" lang="la">Borrelia burgdorferi</span> that is spread to humans and animals through the bite of certain types of ticks and that can have serious consequences if left untreated, including recurring attacks of arthritis and neurological problems;</p><p class="indent-0-0" id="238708">Whereas the risk of exposure to Lyme disease is highest in parts of southern and southeastern Quebec, southern and eastern Ontario, southeastern Manitoba, New Brunswick, Nova Scotia and much of southern British Columbia;</p><p class="indent-0-0" id="238709">Whereas numerous peer-reviewed scientific studies have warned that a warming climate will expand the geographic range of Lyme disease-carrying ticks further into Canada, including a 2012 paper by Leighton et al., which states that over 80% of the population in Eastern and Central Canada could be living in areas at risk of Lyme disease by 2020;</p><p class="indent-0-0" id="238710">Whereas, since 2009, Lyme disease has been a nationally reportable disease in Canada and all medical professionals must report cases of Lyme disease to their provincial public health authority, which in turn provides the data to the Public Health Agency of Canada;</p><p class="indent-0-0" id="238711">Whereas Canadians will benefit from the establishment of guidelines regarding the prevention, identification, treatment and management of Lyme disease, a coordinated national effort to track the spread of the disease, and increased public education and awareness to better prevent and detect instances of Lyme disease in Canada;</p><p class="indent-0-0" id="238712">Whereas recent research further demonstrates the persistence of <span class="otherLang" lang="la">Borrelia</span> spirochetes after antibiotic treatment that follows the guidelines used in Canada (Embers et al., 2012) and indicates that current serology does not adequately describe the diversity of <span class="otherLang" lang="la">Borrelia</span> bacteria existing in Canada and that the general understanding of, and practices for dealing with, Lyme disease are no longer sufficient or in line with emerging evidence of how the disease operates (Ogden et al., 2011);</p><p class="indent-0-0" id="238713">Whereas the current guidelines in Canada are based on those in the United States and are so restrictive as to severely limit the diagnosis of acute Lyme disease and deny the existence of continuing infection, thus abandoning sick people with a treatable illness;</p><p class="indent-0-0" id="238714">And whereas the 2010 report prepared for the Provincial Health Services Authority of British Columbia entitled <cite class="XRefExternal">Chronic Lyme Disease in British Columbia, A Review of Strategic and Policy Issues</cite> concluded that current diagnostic testing for Lyme disease is inadequate and advocated placing the highest priority on the development of reliable diagnostic testing for the disease and on educating physicians so they can recognize the symptoms of Lyme disease and treat patients in a manner that is medically appropriate, including treatment with antibiotics as justified;</p></section><div class="Enacts"><p class="indent-0-0" id="238716">Now, therefore, Her Majesty, by and with the advice and consent of the Senate and House of Commons of Canada, enacts as follows:</p></div><h2 class="Part" id="h-238718"><span class="HTitleText1">Short Title</span></h2><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Short title</p><p class="Section" id="238719"><strong><a class="sectionLabel" id="s-1"><span class="sectionLabel">1</span></a></strong> This Act may be cited as the <cite class="XRefExternalAct"><a href="/eng/acts/F-7.35">Federal Framework on Lyme Disease Act</a></cite>.</p><h2 class="Part" id="h-238721"><span class="HTitleText1">Interpretation</span></h2><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Definitions</p><p class="Section" id="238722"><strong><a class="sectionLabel" id="s-2"><span class="sectionLabel">2</span></a></strong> The following definitions apply in this Act.</p><dl class="Definition"><dt id="238724"><span class="DefinedTerm"><dfn>Agency</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>Agency</dfn></span> means the Public Health Agency of Canada. (<span class="DefinedTermLink" lang="fr">Agence</span>)</p></dd><dt id="238725"><span class="DefinedTerm"><dfn>federal framework</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>federal framework</dfn></span> means a framework to address the challenges of the recognition and timely diagnosis and treatment of Lyme disease. (<span class="DefinedTermLink" lang="fr">cadre fédéral</span>)</p></dd><dt id="238726"><span class="DefinedTerm"><dfn>Minister</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>Minister</dfn></span> means the Minister of Health. (<span class="DefinedTermLink" lang="fr">ministre</span>)</p></dd><dt id="238727"><span class="DefinedTerm"><dfn>provincial and territorial ministers</dfn></span></dt><dd><p class="Definition"><span class="DefinedTerm"><dfn>provincial and territorial ministers</dfn></span> means the provincial and territorial ministers responsible for health. (<span class="DefinedTermLink" lang="fr">ministres provinciaux et territoriaux</span>)</p></dd></dl><h2 class="Part" id="h-238728"><span class="HTitleText1">Federal Framework on Lyme Disease</span></h2><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Conference</p><p class="Section" id="238729"><strong><a class="sectionLabel" id="s-3"><span class="sectionLabel">3</span></a></strong> The Minister must, no later than 12 months after the day on which this Act comes into force, convene a conference with the provincial and territorial ministers and stakeholders, including representatives of the medical community and patients’ groups, for the purpose of developing a comprehensive federal framework that includes</p><ul class="ProvisionList"><li><p class="Paragraph" id="238731"><span class="lawlabel">(a)</span> the establishment of a national medical surveillance program to use data collected by the Agency to properly track incidence rates and the associated economic costs of Lyme disease;</p></li><li><p class="Paragraph" id="238732"><span class="lawlabel">(b)</span> the establishment of guidelines regarding the prevention, identification, treatment and management of Lyme disease, and the sharing of best practices throughout Canada; and</p></li><li><p class="Paragraph" id="238733"><span class="lawlabel">(c)</span> the creation and distribution of standardized educational materials related to Lyme disease, for use by any public health care provider within Canada, designed to increase national awareness about the disease and enhance its prevention, identification, treatment and management.</p></li></ul><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Preparation and publication of report</p><p class="Section" id="238734"><strong><a class="sectionLabel" id="s-4"><span class="sectionLabel">4</span></a></strong> The Minister must prepare a report that sets out the federal framework and publish the report on the Agency’s website within one year after the federal framework referred to in section 3 is developed.</p><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Report to Parliament</p><p class="Section" id="238736"><strong><a class="sectionLabel" id="s-5"><span class="sectionLabel">5</span></a></strong> The Minister must cause a copy of the report referred to in section 4 to be laid before each House of Parliament on any of the first 90 days on which that House is sitting after the report has been published on the Agency’s website.</p><h2 class="Part" id="h-238738"><span class="HTitleText1">Review and Report</span></h2><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Review</p><p class="Section" id="238739"><strong><a class="sectionLabel" id="s-6"><span class="sectionLabel">6</span></a></strong> The Agency must</p><ul class="ProvisionList"><li><p class="Paragraph" id="238741"><span class="lawlabel">(a)</span> complete a review of the effectiveness of the federal framework no later than five years after the day on which the report referred to in section 4 is published on the Agency’s website; and</p></li><li><p class="Paragraph" id="238742"><span class="lawlabel">(b)</span> table a report on its findings before each House of Parliament within the next ten sitting days after the review is completed.</p></li></ul>
</div></section></div>
<!--#include file="iFullDocToc.inc" -->
<!--#include virtual="/includes/gcwu-date-mod-e.inc" -->
</main>
<!--#include virtual="/includes/secmenu_WET4-e.inc" -->
</div>
</div>
<!--#include virtual="/includes/footer_WET4-e.inc" -->
<!--[if gte IE 9 | !IE ]><!-->
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.js"></script>
<script src="/wet-boew/js/wet-boew.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script src="/wet-boew/js/ie8-wet-boew2.js"></script>
<![endif]-->
<script src="/theme-gcwu-fegc/js/theme.js"></script>
<script src="/js/tocCheckjs.js"></script>
<script src="/js/fontChanger.js"></script>
</body>
</html>
